These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 24585723)
1. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042 [TBL] [Abstract][Full Text] [Related]
3. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry. Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494 [TBL] [Abstract][Full Text] [Related]
4. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Tran B; Kopetz S; Tie J; Gibbs P; Jiang ZQ; Lieu CH; Agarwal A; Maru DM; Sieber O; Desai J Cancer; 2011 Oct; 117(20):4623-32. PubMed ID: 21456008 [TBL] [Abstract][Full Text] [Related]
5. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. Santos FA; Reis RM; Barroti LC; Pereira AAL; Matsushita MM; de Carvalho AC; Datorre JG; Berardinelli GN; Araujo RLC J Gastrointest Cancer; 2024 Mar; 55(1):344-354. PubMed ID: 37608030 [TBL] [Abstract][Full Text] [Related]
6. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727 [TBL] [Abstract][Full Text] [Related]
7. High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer. Markovic S; Antic J; Dragicevic N; Hamelin R; Krivokapic Z J Mol Histol; 2012 Apr; 43(2):137-43. PubMed ID: 22210186 [TBL] [Abstract][Full Text] [Related]
8. Impact of Metastasectomy in the Multimodality Approach for Johnson B; Jin Z; Truty MJ; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Grothey A Oncologist; 2018 Jan; 23(1):128-134. PubMed ID: 28904173 [TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
10. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer. Kadowaki S; Kakuta M; Takahashi S; Takahashi A; Arai Y; Nishimura Y; Yatsuoka T; Ooki A; Yamaguchi K; Matsuo K; Muro K; Akagi K World J Gastroenterol; 2015 Jan; 21(4):1275-83. PubMed ID: 25632202 [TBL] [Abstract][Full Text] [Related]
12. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147 [TBL] [Abstract][Full Text] [Related]
13. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis. Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability. Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874 [TBL] [Abstract][Full Text] [Related]
15. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor. Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498 [TBL] [Abstract][Full Text] [Related]
16. Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients. Aasebø KØ; Dragomir A; Sundström M; Mezheyeuski A; Edqvist PH; Eide GE; Ponten F; Pfeiffer P; Glimelius B; Sorbye H Cancer Med; 2019 Jul; 8(7):3623-3635. PubMed ID: 31070306 [TBL] [Abstract][Full Text] [Related]
17. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience. Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439 [TBL] [Abstract][Full Text] [Related]
18. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer. Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910 [TBL] [Abstract][Full Text] [Related]
19. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]